Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism RARγ agonists(Retinoic acid receptor gamma agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | US | 08 Jul 2024 | |
HER2 Positive Breast Cancer | Preclinical | US | 08 Jul 2024 | |
Non-Small Cell Lung Cancer | Preclinical | US | 08 Jul 2024 | |
Prostatic Cancer | Preclinical | US | 08 Jul 2024 | |
Triple Negative Breast Cancer | Preclinical | US | 08 Jul 2024 |